Fungal infections in pediatric patients
ESPID Education. Lehrnbecher T. May 10, 2019; 263160 Disclosure(s): Advisory board: Astellas, Gilead Sciences, MSD, Pfizer Research: Gilead Sciences
Thomas Lehrnbecher
Thomas Lehrnbecher
Only ESPID Members have access to the ESPID 2019 content. To become a member click here
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies